These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 21732131)
1. Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression. Hyseni A; van der Groep P; van der Wall E; van Diest PJ Cell Oncol (Dordr); 2011 Dec; 34(6):565-70. PubMed ID: 21732131 [TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer. Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB Breast Cancer Res; 2007; 9(6):R89. PubMed ID: 18096060 [TBL] [Abstract][Full Text] [Related]
3. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538 [TBL] [Abstract][Full Text] [Related]
4. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer. Vleugel MM; Shvarts D; van der Wall E; van Diest PJ Hum Pathol; 2006 Aug; 37(8):1085-92. PubMed ID: 16867872 [TBL] [Abstract][Full Text] [Related]
5. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Tan EY; Yan M; Campo L; Han C; Takano E; Turley H; Candiloro I; Pezzella F; Gatter KC; Millar EK; O'Toole SA; McNeil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox SB Br J Cancer; 2009 Jan; 100(2):405-11. PubMed ID: 19165203 [TBL] [Abstract][Full Text] [Related]
6. Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha. Shin DH; Li SH; Yang SW; Lee BL; Lee MK; Park JW FEBS J; 2009 Jul; 276(13):3470-80. PubMed ID: 19456861 [TBL] [Abstract][Full Text] [Related]
7. Featured Article: Hypoxia-inducible factor-1α dependent nuclear entry of factor inhibiting HIF-1. Liang K; Ding XQ; Lin C; Kang YJ Exp Biol Med (Maywood); 2015 Nov; 240(11):1446-51. PubMed ID: 25687434 [TBL] [Abstract][Full Text] [Related]
8. BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression. Yan M; Rayoo M; Takano EA; ; Fox SB Br J Cancer; 2009 Oct; 101(7):1168-74. PubMed ID: 19724277 [TBL] [Abstract][Full Text] [Related]
9. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma. Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904 [TBL] [Abstract][Full Text] [Related]
10. DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas. Huang KT; Mikeska T; Dobrovic A; Fox SB Histopathology; 2010 Sep; 57(3):451-60. PubMed ID: 20727020 [TBL] [Abstract][Full Text] [Related]
11. A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}. Li SH; Shin DH; Chun YS; Lee MK; Kim MS; Park JW Mol Cancer Ther; 2008 Dec; 7(12):3729-38. PubMed ID: 19074848 [TBL] [Abstract][Full Text] [Related]
12. [Growth Regulation of Factor Inhibiting Hypoxia-Inducible Factor in Renal Carcinoma Cells]. Deng S; Yang B; Ren ZJ; Dong Q Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):29-33. PubMed ID: 29737085 [TBL] [Abstract][Full Text] [Related]
14. High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer. van der Groep P; Bouter A; Menko FH; van der Wall E; van Diest PJ Breast Cancer Res Treat; 2008 Oct; 111(3):475-80. PubMed ID: 18030615 [TBL] [Abstract][Full Text] [Related]
15. Ferritin heavy chain controls the HIF-driven hypoxic response by activating the asparaginyl hydroxylase FIH. Jin P; Kang J; Lee MK; Park JW Biochem Biophys Res Commun; 2018 May; 499(3):475-481. PubMed ID: 29580991 [TBL] [Abstract][Full Text] [Related]
16. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast. Kuijper A; van der Groep P; van der Wall E; van Diest PJ Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127 [TBL] [Abstract][Full Text] [Related]
17. Regulation of Transactivation at C-TAD Domain of HIF-1 Rani S; Roy S; Singh M; Kaithwas G Oxid Med Cell Longev; 2022; 2022():2407223. PubMed ID: 35592530 [TBL] [Abstract][Full Text] [Related]
18. Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha. Lee YM; Lim JH; Chun YS; Moon HE; Lee MK; Huang LE; Park JW Carcinogenesis; 2009 Oct; 30(10):1768-75. PubMed ID: 19696166 [TBL] [Abstract][Full Text] [Related]